Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Price

Showing results (41-50 of 184) with videos related to

Pageof 19
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|June 13, 2014
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classificationDavid B Price, Christine L Baker, Kelly H Zou, et al.
The European Respiratory Journal|May 21, 2017
Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to TherapyJob F M van Boven, Federico Lavorini, P N Richard Dekhuijzen, et al.
Thorax|September 18, 2017
Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general populationMarjan Kerkhof, Trung N Tran, Joan B Soriano, et al.
Journal of Asthma and Allergy|September 15, 2018
Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational studyDavid B Price, Frank Trudo, Jaco Voorham, et al.
The Lancet. Respiratory Medicine|January 15, 2016
Inhaled corticosteroid dose-response on blood eosinophils in asthma - Authors' replyDavid B Price, Ian D Pavord, Mike Thomas, et al.
Plos One|June 16, 2017
Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroidsSamatha Sonnappa, Richard Martin, Elliot Israel, et al.
Heart (British Cardiac Society)|July 7, 2016
Underuse of β-blockers in heart failure and chronic obstructive pulmonary diseaseBrian Lipworth, Derek Skinner, Graham Devereux, et al.
International Journal of Medical Informatics|December 18, 2022
Defining clinical subtypes of adult asthma using electronic health records: Analysis of a large UK primary care database with external validationElsie M F Horne, Susannah McLean, Mohammad A Alsallakh, et al.
Heart (British Cardiac Society)|November 13, 2016
It is important to distinguish between HFrEF and HFpEF when interpreting these dataBrian Lipworth, Derek Skinner, Graham Devereux, et al.
The Journal of Allergy and Clinical Immunology. Global|January 4, 2024
Predictors of persistent poor control and validation of ASSESS score: Longitudinal 5-year follow-up of severe asthma cohortPei Yee Tiew, Tunn Ren Tay, Wenjia Chen, et al.
Pageof 19

Showing results (41-50 of 184) with videos related to

Sort By:
Pageof 19
International Journal of Chronic Obstructive Pulmonary Disease|June 13, 2014
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classificationDavid B Price, Christine L Baker, Kelly H Zou, et al.
The European Respiratory Journal|May 21, 2017
Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to TherapyJob F M van Boven, Federico Lavorini, P N Richard Dekhuijzen, et al.
Thorax|September 18, 2017
Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general populationMarjan Kerkhof, Trung N Tran, Joan B Soriano, et al.
Journal of Asthma and Allergy|September 15, 2018
Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational studyDavid B Price, Frank Trudo, Jaco Voorham, et al.
The Lancet. Respiratory Medicine|January 15, 2016
Inhaled corticosteroid dose-response on blood eosinophils in asthma - Authors' replyDavid B Price, Ian D Pavord, Mike Thomas, et al.
Plos One|June 16, 2017
Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroidsSamatha Sonnappa, Richard Martin, Elliot Israel, et al.
Heart (British Cardiac Society)|July 7, 2016
Underuse of β-blockers in heart failure and chronic obstructive pulmonary diseaseBrian Lipworth, Derek Skinner, Graham Devereux, et al.
International Journal of Medical Informatics|December 18, 2022
Defining clinical subtypes of adult asthma using electronic health records: Analysis of a large UK primary care database with external validationElsie M F Horne, Susannah McLean, Mohammad A Alsallakh, et al.
Heart (British Cardiac Society)|November 13, 2016
It is important to distinguish between HFrEF and HFpEF when interpreting these dataBrian Lipworth, Derek Skinner, Graham Devereux, et al.
The Journal of Allergy and Clinical Immunology. Global|January 4, 2024
Predictors of persistent poor control and validation of ASSESS score: Longitudinal 5-year follow-up of severe asthma cohortPei Yee Tiew, Tunn Ren Tay, Wenjia Chen, et al.
Pageof 19